Phase II trials are essential because they determine whether a treatment has enough potential benefit to warrant further investigation in larger Phase III trials. These trials help identify the optimal dosing regimens and gather preliminary data on the treatment's impact on specific types of cancer. By focusing on efficacy, Phase II trials help weed out ineffective treatments early in the development process, saving time and resources.
